638219-98-4

Basic information

• Product Name: 7-Chloro-2-Methyl-thieno[3,2-b]pyridine
• Synonyms: 7-Chloro-2-Methyl-thieno[3,2-b]pyridine;7-Chloro-2-Methyl-thieno[...
• CAS NO: 638219-98-4
• Molecular Formula: C₈H₆ClNS
• Molecular Weight: 183.65794
• Mol File: 638219-98-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7-Chloro-2-Methyl-thieno[3,2-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Chloro-2-Methyl-thieno[3,2-b]pyridine(638219-98-4)
• EPA Substance Registry System: 7-Chloro-2-Methyl-thieno[3,2-b]pyridine(638219-98-4)

Safety Data

• Hazardous Substances Data: 638219-98-4(Hazardous Substances Data)

Usage

General Description

7-Chloro-2-Methyl-thieno[3,2-b]pyridine is a chemical compound with the molecular formula C7H5ClNS. It is a heterocyclic aromatic compound with a thienopyridine core structure. 7-Chloro-2-Methyl-thieno[3,2-b]pyridine is widely used in the pharmaceutical industry as a building block for the synthesis of various pharmaceutical drugs and drug candidates. It is also used in the research and development of new drugs due to its unique structure and potential biological activities. Additionally, 7-Chloro-2-Methyl-thieno[3,2-b]pyridine is known for its potential anti-inflammatory and anticancer properties, making it a valuable compound for medical research and drug discovery.

Upstream product

• 69627-03-8 7-chlorothieno[3,2-b]pyridine 
• 74-88-4 methyl iodide 

Relevant articles and documents

Aurora Kinase Modulators and Method of Use

The present invention relates to chemical compounds having a general formula I wherein A1-8, D′, L1, L2, R1, R6-8 and n are defined herein, and synthetic intermediates, which are capable of modulating various protein kinase receptor enzymes and, thereby, influencing various disease states and conditions related to the activities of such kinases. For example, the compounds are capable of modulating Aurora kinase thereby influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of Aurora kinase.

BENZOFUSED HETEROARYL AMIDE DERIVATIVES OF THIENOPYRIDINES USEFUL AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME, AND METHODS FOR THEIR USE

The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.